6505--TheraSphere Y-90 Glass Microspheres - Miami VAMC

The Department of Veterans Affairs Veterans Health Administration Network Contracting Office 8 in Miami, Florida has issued a Special Notice announcing its intent to award a sole source contract for TheraSphere Y-90 Glass Microspheres. The procurement is specifically for FDA-approved liver cancer therapy supplies that will be provided by Boston Scientific under a firm fixed price contract. The notice is issued under Federal Acquisition Regulation (FAR) 6.302-1 authority, which allows for sole source procurement when only one responsible supplier can meet the agency's requirements. The solicitation falls under NAICS code 325412 for Surgical Appliance and Supplies Manufacturing, with a small business size standard of 1,300 employees. This procurement serves the Miami VA Medical Center's specialized medical treatment needs for liver cancer patients.

The primary purpose of this Special Notice is to formally announce the government's determination that Boston Scientific is the only source capable of providing the required TheraSphere Y-90 Glass Microspheres, emphasizing that this is not a competitive procurement opportunity. Interested businesses have until October 17, 2025 at 5:00 PM Eastern Time to submit written responses if they believe they can provide similar supplies, with all communications directed to Contracting Officer John Quijada Jr. at john.quijadajr@va.gov. The notice explicitly states that no solicitation documents are available and telephone requests will not be accepted. While this is structured as a sole source award, the government has provided an opportunity for other potential suppliers to challenge this determination by submitting written notice of their capabilities. The procurement focuses exclusively on this specialized medical device used in liver cancer therapy, reflecting the VA's commitment to providing advanced treatment options for veterans.